Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by investorpluson May 19, 2010 10:50am
369 Views
Post# 17113211

RE: RE: RE: RE: MEDIASCAN WHERE ARE YOU?

RE: RE: RE: RE: MEDIASCAN WHERE ARE YOU?Ditto twebca;

Evryone, please just take a deep breath and relax. This is highly unusual and smell like a move from someone to trigger stop lost in the aim of getting cheap shares before the NR comes out.

Call me a fool, but I still think that the NR will be positive.

Mediascan always been fair in his analysis and I would ask everyone to just relax and not blame anyone else for their own decision.

Time will tell.

Sincerely,

GLTA
Bullboard Posts